Manny has 24 years of pharmaceutical industry and management consulting experience, specializing in predictive modeling and advanced analytics, sales force effectiveness, multi-channel marketing, aggregate spend/disclosure strategy and analysis and information technology. Prior to founding Helio, Manny was a Managing Director at Huron Consulting Group where he was a senior partner in the life sciences practice. Before joining Huron, Manny was a Client Partner in the life sciences practice for Fair Isaac Corporation (FICO), where he was the expert on pharmaceutical data management and multi-channel marketing best practices. Prior to Fair Isaac Corporation, Manny created and managed the Professional Services Group (PSG) at Dendrite International as Managing Director, and was also a senior executive with Accenture’s Pharmaceutical & Medical Products Customer Relationship Management (CRM) division. Manny began his career in sales, sales operations and business analysis at Novartis Pharmaceuticals / Ciba Geigy.
Marci is a seasoned management consultant with over 16 years of pharmaceutical experience. She specializes in advising life science companies on optimizing operational processes while addressing compliance. Areas she focuses on include aggregate spend/disclosure, patient services support, sales and marketing, medical affairs, and clinical trials. Her extensive experience includes providing pharmaceutical, medical device and biotechnology companies with effective advice on program implementation, operational excellence, change management, data analytics, compliance adherence, and risk mitigation. Prior to Helio, Marci was a Director at Huron Consulting Group’s Life Sciences Practice. Marci began her career in Ernst & Young’s Fraud, Investigation and Dispute Services group focusing on healthcare challenges.
partneR and CTO
John is a Technology Executive with many years of product development and pharmaceutical management consulting experience. He is a successful software start-up technology entrepreneur with the distinction of being the Chief Architect to a vertical search start-up sold to Forbes Media and the Chief Architect to a social media start-up sold to the New York Times Digital. John is currently focusing on small-data engineering approaches to patient service risk abatement and patient data privacy concerns.